Picture a horse running across an open field, the wind blowing his mane, his hooves stamping into the grassy knoll, eyes on ...

Patient age in uveitis diagnoses and treatment plays a significant role, according to research published in American Journal of Ophthalmology.

Patients with varying stages of glaucoma saw no significant difference in outcomes between standard and enhanced monofocal ...

Goniotomy may be a first-line approach to treating pediatric patients with glaucoma secondary to uveitis, with improvements ...

ALPHARETTA, Ga. - Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company with a market capitalization of $85.7 million focused on developing therapies for ocular diseases, has announced ...

Reports Q3 revenue $9.02M, consensus $4.75M. “Roivant has broadened our clinical pipeline with the newly announced trial of brepocitinib in ...

A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...

"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ...

Treatment Landscape The treatment of uveitis has evolved significantly, with a focus on reducing inflammation, managing symptoms, and preventing complications. Key treatment options include ...

Infliximab is more effective and safer than etanercept in the treatment of patients with noninfectious uveitis. Adalimumab is valid for severe uveitis, reducing efficacy for treatment of infliximab.

The research also uncovered a genetic correlation between anterior uveitis and inflammatory bowel diseases (IBD). These findings contribute to a better understanding of the mechanisms behind ...